Cogent Biosciences
COGT
#3149
Rank
NZ$8.80 B
Marketcap
NZ$50.61
Share price
-0.25%
Change (1 day)
-18.68%
Change (1 year)

Earnings for Cogent Biosciences (COGT)

Earnings in 2026 (TTM): -NZ$0.65 Billion

According to Cogent Biosciences's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.6 Billion a decrease over its 2024 earnings that were of -NZ$0.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cogent Biosciences from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.65 Billion8.77%
2025 -NZ$0.6 Billion22.64%
2024 -NZ$0.49 Billion27.67%
2023 -NZ$0.38 Billion40.78%
2022 -NZ$0.27 Billion95.68%
2021 -NZ$0.14 Billion114.09%
2020 -NZ$64.38 Million9.67%
2019 -NZ$58.71 Million-10.63%
2018 -NZ$65.69 Million37.68%
2017 -NZ$47.71 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.3 Billion-57.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$33.13 Million-95.12%๐Ÿ‡บ๐Ÿ‡ธ USA